Literature DB >> 7971724

Sustained suppression of the pituitary-gonadal axis by leuprorelin three-month depot microspheres in rats and dogs.

H Okada1, Y Doken, Y Ogawa, H Toguchi.   

Abstract

The pharmacological effects of leuprorelin three-month depot microspheres were investigated in rats and dogs. After s.c. and i.m. injection, the microspheres provided similar linear drug release and sustained serum drug levels for 3 months. Persistent suppression of serum LH, FSH (in rats) and testosterone (in rats and dogs) for over 16 weeks was achieved when the microspheres were given at a dose of 100 (rat) and 25.6 (dog) micrograms/kg/day. These hormone release responses upon periodic challenge tests revealed that a single injection of the microspheres caused dramatic suppression of the function of the pituitary-gonadal system for 15 weeks in rats. The growth of the genital organs was also suppressed dose-dependently by injection of the microspheres over 3 months; the strongest suppression was achieved at a dose of 100 micrograms/kg/day. This three-month depot formulation is expected to be more convenient than the one-month depot with improved patient compliance and therapeutic effects.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7971724     DOI: 10.1023/a:1018905403359

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  7 in total

1.  Sustained pharmacological activities in rats following single and repeated administration of once-a-month injectable microspheres of leuprolide acetate.

Authors:  H Okada; T Heya; Y Ogawa; H Toguchi; T Shimamoto
Journal:  Pharm Res       Date:  1991-05       Impact factor: 4.200

2.  In vivo release profiles of leuprolide acetate from microcapsules prepared with polylactic acids or copoly(lactic/glycolic) acids and in vivo degradation of these polymers.

Authors:  Y Ogawa; H Okada; M Yamamoto; T Shimamoto
Journal:  Chem Pharm Bull (Tokyo)       Date:  1988-07       Impact factor: 1.645

3.  One-month release injectable microcapsules of a luteinizing hormone-releasing hormone agonist (leuprolide acetate) for treating experimental endometriosis in rats.

Authors:  H Okada; T Heya; Y Ogawa; T Shimamoto
Journal:  J Pharmacol Exp Ther       Date:  1988-02       Impact factor: 4.030

4.  Long-acting delivery systems for peptides: inhibition of rat prostate tumors by controlled release of [D-Trp6]luteinizing hormone-releasing hormone from injectable microcapsules.

Authors:  T W Redding; A V Schally; T R Tice; W E Meyers
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

5.  Pharmacokinetics of once-a-month injectable microspheres of leuprolide acetate.

Authors:  H Okada; Y Inoue; T Heya; H Ueno; Y Ogawa; H Toguchi
Journal:  Pharm Res       Date:  1991-06       Impact factor: 4.200

6.  Preparation of three-month depot injectable microspheres of leuprorelin acetate using biodegradable polymers.

Authors:  H Okada; Y Doken; Y Ogawa; H Toguchi
Journal:  Pharm Res       Date:  1994-08       Impact factor: 4.200

7.  Controlled release of a luteinizing hormone-releasing hormone analogue from poly(d,l-lactide-co-glycolide) microspheres.

Authors:  L M Sanders; J S Kent; G I McRae; B H Vickery; T R Tice; D H Lewis
Journal:  J Pharm Sci       Date:  1984-09       Impact factor: 3.534

  7 in total
  6 in total

1.  In vitro characterization and in vivo testosterone suppression of 6-month release poly(D,L-lactide) leuprolide microspheres.

Authors:  Byung Ho Woo; Kyu-Heum Na; Bhas A Dani; Ge Jiang; B C Thanoo; Patrick P DeLuca
Journal:  Pharm Res       Date:  2002-04       Impact factor: 4.200

Review 2.  Clinical pharmacokinetics of depot leuprorelin.

Authors:  Piero Periti; Teresita Mazzei; Enrico Mini
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

3.  Preparation and characterization of a composite PLGA and poly(acryloyl hydroxyethyl starch) microsphere system for protein delivery.

Authors:  B H Woo; G Jiang; Y W Jo; P P DeLuca
Journal:  Pharm Res       Date:  2001-11       Impact factor: 4.200

4.  Estropause, Sex Hormones and Metal Homeostasis in the Mouse Brain.

Authors:  Tianbing Liu; Richard L Bowen; Andrea C Wilson; Craig S Atwood
Journal:  Front Neurol       Date:  2022-05-11       Impact factor: 4.086

5.  Comprehensive assessment of the effect of Sphenocentrum jollyanum root extract on male reproductive activity in albino rats.

Authors:  Yinusa Raji; Olayemi O Fadare; Rahmat A Adisa; Shakiru A Salami
Journal:  Reprod Med Biol       Date:  2006-11-23

Review 6.  Therapeutics in ferrets.

Authors:  B H Williams
Journal:  Vet Clin North Am Exot Anim Pract       Date:  2000-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.